Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of intraoperative blood loss during caesarean section in women at high risk of postpartum haemorrhage
PACTR202512762458292Phase 3Not yet recruiting
- Sponsor
- Agbanu Chiemezie
- Start
- Dec 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Carbetocin prophylaxis with Oxytocin prophylaxis (2 arms). Primary endpoint: Need for additional uterotonics. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202512762458292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512762458292.